News (212)

Transcript : UroGen Pharma Ltd. - Special Call
Transcript : Allogene Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024
Transcript : UroGen Pharma Ltd. - Special Call
Kronos Bio : Management Change/Compensation - Form 8-K PU
Transcript : Ginkgo Bioworks Holdings, Inc. Presents at Cowen 43rd Annual Healthcare Conference, Mar-06-2023 through Mar-08-2023
Investigational Therapy UGN-102 May Be Delivered at Home for the Treatment of Bladder Cancer BU
Astrazeneca - Acquisition of Neogene Therapeutics completed AQ
Acquisition of Neogene Therapeutics completed AQ
Allogene Therapeutics R&D Showcase Features Hematologic and Solid Tumor Advances Across its AlloCAR T™ Platform GL
Allogene Therapeutics R&D Showcase Features Hematologic and Solid Tumor Advances Across its AlloCAR T™ Platform GL
Transcript : Allogene Therapeutics, Inc. - Special Call
AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy AQ
Ginkgo Bioworks To Present New Data on High Throughput Pooled Screening Method to Discover Novel CAR-T Designs for Solid Tumors PR
ALLOGENE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
GINKGO BIOWORKS HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
UROGEN PHARMA LTD. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
Transcript : UroGen Pharma Ltd. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-13-2022 09:45 AM
Transcript : Ginkgo Bioworks Holdings, Inc., Q3 2021 Earnings Call, Nov 15, 2021
Transcript : UroGen Pharma Ltd. - Special Call
UroGen Pharma to Host Virtual Spotlight Event on November 10, 2021 BU
Ginkgo Bioworks Previews Today's Annual Ferment Conference PR
GINKGO BIOWORKS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Registrant's Certifying Accountant, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Other Events, Financial Statements and Exhibits (form 8-K) AQ
Ginkgo Bioworks to Begin Trading Today as NYSE: DNA with Over $1.6 Billion in Proceeds PR
Ginkgo Bioworks, Inc. completed the acquisition of Soaring Eagle Acquisition Corp. from Eagle Equity Partners III, LLC and others. CI
Soaring Eagle Acquisition : Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds (Form 8-K) PU
Soaring Eagle Acquisition : Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds BU
Soaring Eagle Acquisition : Vertex CEO Reshma Kewalramani, MD to join Ginkgo Bioworks Board of Directors PR
Vida Ventures : Closes $825 Million Vida III Fund to Advance Transformative Biomedical Innovations BU
UROGEN PHARMA LTD. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
Soaring Eagle Acquisition : Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming (Form 8-K) PU
Ginkgo Bioworks : to Become a Public Company and Expand its Leading Platform for Cell Programming PR
Transcript : Ginkgo Bioworks, Inc., Soaring Eagle Acquisition Corp. - Pre Recorded M&A Call
Ginkgo Bioworks, Inc. entered into definitive agreement to acquire Soaring Eagle Acquisition Corp. from Eagle Equity Partners III, LLC and others for $16.7 billion in a reverse merger transaction. CI
IconOVir Bio Raises $77 Million in Series A Financing to Develop Next-Generation Oncolytic Viruses to Treat Solid Tumors BU
Transcript : Syncona Limited, H1 2021 Earnings Call, Nov 19, 2020
Transcript : Twist Bioscience Corporation - Shareholder/Analyst Call
Syncona : Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies PU
Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies BU
Jeito Capital co-leads $110 Million Series A Financing in Neogene Therapeutics GL
Jeito Capital co-leads $110 Million Series A Financing in Neogene Therapeutics GL
UROGEN PHARMA LTD. : Changes in Registrant's Certifying Accountant, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
Transcript : UroGen Pharma Ltd. - Shareholder/Analyst Call
Transcript : Allogene Therapeutics, Inc., Q1 2020 Earnings Call, May 06, 2020
Allogene Therapeutics Announces Year-End 2019 Media Event and Investor Conference Schedule GL
Transcript : UroGen Pharma Ltd. - Analyst/Investor Day
1234NextSee all

Companies (19)

ASTERA LABS, INC. 9 826 M $
Logo Astera Labs, Inc.

Astera Labs, Inc. provides semiconductor-based connectivity solutions for cloud and artificial intelligence (AI) infrastructure. The Company has developed and deployed its Intelligent Connectivity Platform built from the ground up for cloud and AI infrast ...

APPLIED THERAPEUTICS, INC. 601 M $
Logo Applied Therapeutics, Inc.

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, g ...

BOSS HOLDINGS, INC. 25 M $
Logo Boss Holdings, Inc.

Boss Holdings, Inc. is engaged in the importing, marketing and distribution of pet supplies and cell phone accessories, as well as custom imprinting of inflatable and other products for the advertising specialties industry. The Company operates through th ...

TACHENG REAL ESTATE CO.,LTD. 132 M $
Logo Tacheng Real Estate Co.,Ltd.

Tacheng Real Estate Co Ltd, formerly Taiwan Aries Co Ltd, is a Taiwan-based company principally engaged in the development, sale and leasing of residential buildings. The Company is mainly engaged in the development, construction, trading and leasing of r ...

LUX ISLAND RESORTS LTD 155 M $
Logo Lux Island Resorts Ltd

LUX Islands & Resorts Ltd specializes in hotel operating. Net sales break down by activity as follows: - accommodation services (58.2%); - catering services (31.7%); - other (10.1%). At the end of June 2022, the group owns 7 hotels and resorts under t ...

EDEN HOTEL LANKA PLC 70 M $
Logo Eden Hotel Lanka PLC

Eden Hotel Lanka PLC is a Sri Lanka-based company, which operates hotels in Sri Lanka. The Company’s principal activity is carrying on the business of a Hotelier. The Company operates its hoteliering and hotel management business, through its subsidiari ...

CEMENTO POLPAICO S.A. 223 M $
Logo Cemento Polpaico S.A.

Cemento Polpaico SA is a Chile-based company principally engaged in the cement industry. The Company’s activities include primarily the production and distribution of Pozzolanic cement, as well as Portland and gravel and sand aimed at the production of ...

REYSAS GAYRIMENKUL YATIRIM ORTAKLIGI 618 M $
Logo Reysas Gayrimenkul Yatirim Ortakligi

Reysas Gayrimenkul Yatirim Ortakligi AS is a Turkey-based real estate investment trust, engaged in real estate investments, real estate-backed rights and capital instruments, as well as other capital market instruments within the regulatory framework set ...

VILNIAUS BALDAI AB 38 M $
Logo Vilniaus Baldai AB

Vilniaus Baldai AB (Vilniaus baldai JSC), formerly Vilniaus baldu kombinatas AB, is a Lithuania-based company involved in the furniture industry. The Company specializes in the design, production and sale of furnishings. Vilniaus Baldai AB's products port ...

ARIS MINING CORPORATION 584 M $
Logo Aris Mining Corporation

Aris Mining Corporation is a Canada-based company, which is primarily engaged in the acquisition, exploration, development and operation of gold properties in Colombia, Guyana and Canada. The Company operates the Segovia Operations and Marmato Mine in Col ...

PT ARITA PRIMA INDONESIA TBK 11 M $
Logo PT Arita Prima Indonesia Tbk

PT Arita Prima Indonesia Tbk is an Indonesia-based company engaged in importing, distributing, and servicing valves, fittings, instrumentation, and control products. The Company operates in the pipe industry and the wholesale trading of engines, spare par ...

SOFTWARE AG 2 832 M $
Logo Software AG

Software AG is a Germany-based software developer and provider of information technology (IT) platforms for businesses. The Company operates in three segments: Digital Business Platform (DBP), Adabas & Natural (A&N) and Consulting. The DBP segment focuses ...

ABOITIZ POWER CORPORATION 4 268 M $
Logo Aboitiz Power Corporation

Aboitiz Power Corp. is a holding company. The Company holds investments in power generation and distribution companies in the Philippines. The Company’s segments include Power Generation, Power Distribution, Parent Company and Others. The Power Generati ...

ARIS WATER SOLUTIONS, INC. 443 M $
Logo Aris Water Solutions, Inc.

Aris Water Solutions, Inc. is an environmental infrastructure and solutions company. The Company helps customers reduce their water and carbon footprints. It delivers full-cycle water handling and recycling solutions for energy operations. Its integrated ...

PALM GARDEN HOTELS PLC 66 M $
Logo Palm Garden Hotels PLC

Palm Garden Hotels Plc is a Sri Lanka-based company. The principal activity of the Company is carrying on the business of hotelier. The Company operates its hoteliering and hotel management business, through its subsidiaries, which include Eden Hotel Lank ...

CYPRUS TRADING CORPORATION PLC 16 M $
Logo Cyprus Trading Corporation Plc

Cyprus Trading Corp Plc is a trading organization in Cyprus. The Company has four divisions: CTC Argosy, which deals with fast moving consumer goods; CTC Automotive, for vehicles and heavy machinery; CTC Cassandra, for tobacco products and CTC Domex that ...

ODESSA MINERALS LIMITED 2 M $
Logo Odessa Minerals Limited

Odessa Minerals Limited is an Australia-based rare earth element (REE), lithium (Li) and diamond exploration company with a tenement holding of over 4,000 square kilometers (km2) in the Gascoyne and Kimberley Regions of Western Australia. The Lyndon REE/L ...

ARIES AGRO LIMITED 38 M $
Logo Aries Agro Limited

Aries Agro Limited is engaged in the business of manufacturing micronutrients and other nutritional products for plants and animals. The Company operates through the Agro Inputs segment. Its products and services include micronutrients, water-soluble NPK, ...

ERMES DEPARTMENT STORES PLC 4 M $
Logo Ermes Department Stores Plc

Ermes Department Stores PLC, a member of the Shacolas Group, is a Cyprus-based company active in the import, wholesale and retail of consumer products, such as fashion, cosmetics and home furnishing items. It operates Debenhams Department Stores in Nicosi ...


12Next

Insiders

Picture Arie Belldegrun
Arie Belldegrun

Arie S. Belldegrun is an entrepreneur and businessperson who founded 6 companies, among them: Kite Pharma, Inc., Allogene Therapeutics, Inc. and Agensys, Inc. and who has been at the head of 16 different companies. Presently, he holds the position of Chairman & Partner at Two River Group Holdings LLC, Chairman for Two River Group Management LLC, Chairman at Bellco Capital LLC (which he founded in 2003), Chairman at Two Rivers Consulting Corp., Chairman for UroGen Pharma Ltd., Chairman & Partner at Two River Consulting LLC, Executive Chairman of Allogene Therapeutics, Inc. (which he founded in 2017), Chairman of Kronos Bio, Inc., Co-Chairman at Breakthrough Properties LLC, Senior Managing Director at VV Manager LLC (which he founded in 2017), Senior Managing Director at Vida Ventures LLC (which he founded in 2017) (a subsidiary of VV Manager LLC) and Chairman of Technology Assessment Group. Arie S. Belldegrun is also Director & Professor at UCLA Institute of Urologic Oncology, Head-Urologic Oncology Division at David Geffen School of Medicine and Senior Managing Director at Vida Ventures LLC (he founded the company in 2017) and on the board of 5 other companies. Dr. Belldegrun previously was Chairman of Arno Therapeutics, Inc. and Non-Executive Chairman at Arno Therapeutics, Inc. (a subsidiary of Arno Therapeutics, Inc.), Chairman, President & Chief Executive Officer at Equinor ASA, Director at Agensys, Inc. (he founded the company in 1997), Executive Chairman, President & CEO at Kite Pharma, Inc. (he founded the company in 2009), Chairman-Molecular Biological Technology Committee at American Urological Association Education & Research, Inc., Researcher at National Cancer Institute and Member of Los Angeles Economy & Jobs Committee. Arie S. Belldegrun received a doctorate from The Hebrew University Hadassah Medical School and a graduate degree from Weizmann Institute of Science.




Picture Arie Kotler
Arie Kotler

Mr. Arie E. Kotler is a Chairman, President & Chief Executive Officer at ARKO Corp., a Chief Executive Officer at GPM Investments LLC, a Chairman, President & Chief Executive Officer at GPM Petroleum (DE) LP, a Chief Executive Officer at Haymaker Acquisition Corp. II, a Chief Executive Officer at Village Pantry LLC and a Chief Executive Officer at Worsley Operating Co. LLC. He is on the Board of Directors at Noga Financial Instruments (Dollar) Ltd., Noga Financial Instruments (Dollar) Trading 2004 Ltd. and Yahli Group Ltd. Mr. Kotler was previously employed as a Chairman by Halman Aldubi Investments House Ltd., a Chairman by Ligad Investments & Building Ltd., a Chairman by Malrag 2011 Engineering & Construction, and a Chairman & Chief Executive Officer by Arko Holdings Ltd.


Picture Arie Mientkavich
Arie Mientkavich

Arie Mientkavich is currently the Chairman of several organizations, including RDC - Rafael Development Corp.
Ltd., The Movement For Quality Government In Israel, Yad Sarah, RDSeed Ltd., IDB Tourism (2009) Ltd., A.
Mientkavich Consultation Ltd., Hillel Israel Ltd., Yozma Pension Fund of Self Employed Ltd., Migdal Insurance Co. Ltd., Migdal Makcfet Pension & Provident Funds Ltd., and Bloomfield Science Museum.
He is also a Director at Israel Bar Association since 1972.
In the past, he served as the Chairman of Elron Ventures Ltd.
from 2007 to 2015, Vice Chairman of IDB Holding Corp.
Ltd.
from 2010 to 2014, Chairman of Israel Discount Bank Ltd.
from 1997 to 2006, Chairman-Balance Sheet Committee at Mercantile Discount Bank Ltd., Deputy Chairman of G City Ltd.
from 2011 to 2016, Chairman of Clal Tourism Ltd.
from 2007 to 2011, Chairman of Elron Software, Inc., Chairman of Israel Discount Bank of New York, Chairman of Amos Luzon Development & Energy Group Ltd., Vice Chairman-Supervisory Board of Ronson Development SE from 2012 to 2016, Chairman of Gazit Globe Israel (Development) Ltd., Chairman of U.
Dori Construction Ltd.
in 2016, Chairman of U.
Dori Group Ltd., Director at Given Imaging Ltd.
from 2007 to 2014, Director at Migdal Insurance & Financial Holdings Ltd.
from 2019 to 2021, Director at NuLens Ltd., Director at Medingo Ltd., and Member-License Committee at Bank of Israel.
He holds undergraduate and graduate degrees from The Hebrew University of Jerusalem.


Picture Arie Sharon
Arie Sharon

Arie Sharon is currently working as the VP-Planning, Engineering & Construction at Azrieli Group Ltd.
Previously, he worked as the VP-Engineering & Business Development at Aura Investments Ltd.
Mr. Sharon completed his undergraduate degree at Technion-Israel Institute of Technology.


Picture Arie A. van ’t Hof
Arie A. van ’t Hof

Presently, Arie A. van ’t Hof occupies the position of Chief Financial Officer at HAL Trust. He previously occupied the position of Chief Financial Officer of HAL Holding NV.


Picture Ron Belldegrun
Ron Belldegrun

Ron Belldegrun is the founder and the Chief Executive Officer of ByHeart, Inc., a company founded in 2016.
He is also the founder and the Managing Partner of Consumer Health Ventures LLC, which is also founded in 2016.
Mr. Belldegrun previously worked as an Investor at Visium Asset Management LP.
He completed his undergraduate degree at the University of Pennsylvania in 2008.


Picture Ben Belldegrun
Ben Belldegrun

Ben Belldegrun is the founder of Aliment Capital LLC, where he holds the title of Managing Partner starting in 2014.
He is also the founder of Lodestone BV.
Currently, Mr. Belldegrun holds director positions at Anuvia Plant Nutrients Corp., Concentric Ag Corp., Tropic Biosciences UK Ltd., Pairwise Plants Services, and Concentric Agriculture, Inc. Mr. Belldegrun's former position was as a Portfolio Manager at Brevan Howard Asset Management LLP from 2008 to 2011.
Mr. Belldegrun received his undergraduate degree from The Trustees of Columbia University in The City of New York in 1998 and his MBA from the University of California, Los Angeles in 2004.



Picture Rebecka Belldegrun
Rebecka Belldegrun

Rebecka Belldegrun is the founder of Bellco Capital LLC, where she holds the titles of President & Chief Executive Officer from 2003.
She is also the founder of Intertech Corp.
Dr. Belldegrun's current jobs include Director positions at BabyfirstTV, Breakthrough Properties LLC, Breakthrough Properties Growth Portfolio I LP, Trustee positions at California Institute of Technology and Museum Associates.
Dr. Belldegrun's former jobs include Director positions at First Media Corp.
and Independent Director position at Kronos Bio, Inc. Dr. Belldegrun received an undergraduate degree from Tel-Aviv University.






Picture Arie Biger
Arie Biger

Arie Biger worked as an Internal Auditor at Maslavi Construction Co. Ltd..
Mr. Biger attended Bar-Ilan University for his undergraduate degree.




Picture Arie Israel
Arie Israel

Arie Israel worked as an Internal Auditor at IMCO Industries Ltd.
from 2005 to 2016.
He obtained an undergraduate degree from Tel-Aviv University.









Picture Arie Holtz
Arie Holtz

Arie Holtz is currently the Chief Financial Officer at Tryko Partners LLC.
Previously, he worked as the Vice President of Research & Development at Aespira Ltd.
Mr. Holtz has an undergraduate degree from Technion-Israel Institute of Technology and an MBA from Heriot-Watt University.




Picture Arié Assayag
Arié Assayag

Mr. Assayag is the CEO of Nexar Capital Group, founded in April 2009.
Prior to that, he was the Global Head of Hedge Funds for SG Asset Management Alternative Investments ("SG AM").
Mr. Assayag joined SG Asset Management in 1999 to launch SG AM's Hedge Fund platform.
His team has won several industry awards including Institutional Firm of the Year 2005 (InvestHedge) and Best Hedge Fund of the Year 2008 in Volatility (Eurohedge, HF Review).
Previously, from 1994 to 1999, he was a founding partner and Head of FX Derivatives at Commerz Financial Products (a subsidiary of Commerz Bank).
In 1994, he was Head of EMS FX Derivatives at Citibank in New York.
Prior to that, from 1985 to 1993, Mr. Assayag was at Société Générale and participated in building the Bank's global derivatives business, working in Tokyo as Head of Asia from 1987 to 1990 and working in Chicago as Head of US exchange activity from 1990 to 1993.
Mr. Assayag holds a degree in Engineering and Applied Mathematics from Ecole Centrale of Paris (ECP).



Picture Arie Dekker
Arie Dekker

Mr. Arie Dekker is an Analyst at Jarden Securities Ltd.
He is also the Head of Research and leads research division, providing clients with insights into New Zealand listed companies.
His team regularly engages with industry contacts, companies, regulatory bodies and a range of other sources to find interesting angles that will help shape clients’ investment decisions.
His areas of expertise include telecommunications and media, dairy, the retirement village sector, and building products.
Mr. Dekker was employed as a Research Analyst by Craigs Investment Partners Ltd., a Senior Investment Analyst by Todd Capital Ltd., Todd Capital Ltd., a Chief Financial Officer & Director by ARA Wines Ltd., an Analyst by Deutsche Bank AG (Broker), and a Principal by First NZ Capital Ltd.
He received his MBS (First Class Honors) from Massey University.









Picture Arie Santinge
Arie Santinge

Arie Santinge is currently working as a Financial Controller & Compliance officer at Ausnutria Hyproca BV.
He completed his undergraduate degree from Nyenrode Business Universiteit in 1991.


Picture Arie Weber
Arie Weber

Arie Weber is currently the Chief Executive Officer at Scorpio Investments (A.W.) Ltd., Top Invest (W.M.) Ltd., and holds director positions at Suny Cellular Communication Ltd., Excellence Nessuah Asset Management Ltd., Lapidoth-Heletz LP, Lapidoth-Heletz 2004 (Management) Ltd., Flora Fotonica Ltd., Excellence Nessuah Brokerage Serives Ltd., and E.S.T.
Ecological Systems Ltd.
In the past, Mr. Weber served as the Chief Executive Officer at Alonei Meitar Ltd.
from 2006 to 2009.
He was also the Chairman of The Tel-Aviv Stock Exchange Clearing House Ltd.
and Inventec Investments Ltd.
from 2004 to 2008.
Additionally, he held director positions at Lapidoth Capital Ltd.
and Phoenix Investments House Ltd.
Furthermore, Mr. Weber served as an Independent Director at Capital Point Ltd.
from 2014 to 2023.
He was also a director at The Tel Aviv Stock Exchange (Investment Management) and Purple Biotech Ltd.
.
Mr. Weber's education includes an undergraduate degree and an MBA from Kharkiv National University.




Picture Arie Weintraub
Arie Weintraub

Arie Weintraub worked as a Director at Maman Cargo Terminals & Handling Ltd.
from 2016 to 2019.
He received his undergraduate and MBA degrees from Bar-Ilan University.








Picture Arie Zigler
Arie Zigler

Arie Zigler is associated with two companies, HIL Applied Medical Ltd.
and Resight Ltd.
He is the founder of both companies.
At HIL Applied Medical Ltd., he holds the title of Chief Scientist starting from 2010.
At Resight Ltd, he holds the title of Head-R&D Load starting from 2019.






Picture Arie Ben-Josef
Arie Ben-Josef

Arie Ben-Josef is the founder of Novo Path Ltd.
where he holds the title of Chief Executive Officer starting in 2012.
He is currently a Director at A.R Guide In Medical Ltd.
Dr. Ben-Josef's former position was as Chief Executive Officer at ETView Ltd.





Picture Arie Kimel
Arie Kimel

Arie Kimel was the President and Chief Executive Officer at Bonus Biogroup Ltd.



Picture Michel Arié
Michel Arié

Michel Arié is currently the Deputy Chairman-Management Board at CNIM Development SA. He also holds non-executive director positions at SPI-bio SA, WWS Holdings Ltd., Babcock Wanson Caldeiras Lda., Babcock Wanson España, CNIM Escalators UK Ltd., CNIM CZ sro, CNIM ECS Ltd., and Mese Ltd.
Additionally, he is the Director at Biotec Centre SA, Ellipse Pharmaceuticals SAS, and LAB GmbH.
Mr. Arié is the President of Atena.
In the past, he served as a non-executive director at Le Lab SA, Bertin Technologies SAS, HWS Holdings Ltd., Energonut SpA, MES SELCHP Ltd., Pantech SA, Babcock Wanson UK Ltd., and CNIM UK Ltd.
He was also an independent director at Valerio Therapeutics SA from 2012 to 2013.
Mr. Arié worked as the Head-Finance & Acquisitions at CNIM Group SA from 2010 to 2011.
He completed his undergraduate degree at Institut d’Administration des Entreprises.






Picture Arie Berggrun
Arie Berggrun

Prior to joining AM Investments, Mr. Berggrun was with Caxton Associates.



Picture Arie Westerlaken
Arie Westerlaken

Arie Westerlaken formerly worked at DAF Trucks NV, as Director-Legal Affairs from 1990 to 1994, Koninklijke Philips NV, as Secretary & Chief Legal Officer from 1994 to 2010, and BlackRock (Netherlands) BV, as Chief Legal Officer from 1996 to 2007.
Mr. Westerlaken received his graduate degree from the University of Utrecht.








Picture Arie Bernardo
Arie Bernardo

Arie Bernardo is currently a Principal at WTP Capital LLC.
Previously, she worked as a Treasury Officer at Universal Robina Corp.
She received both undergraduate and graduate degrees from the University of the Philippines.


Picture Arie Carasso Lev
Arie Carasso Lev

Arie Carasso-Lev has founded Globe Energy Resources Y.C.D LP in 2009, where he holds the title of Chairman.
He is currently the Chief Executive Officer at Globe International Holdings SA since 2007, at T.D.E.
Recovery Technologies Ltd.
since 2008, and at Pro Line Engineering Services Ltd.
since 1988.
Mr. Carasso-Lev has an undergraduate degree from The California State University.





Picture Arie Kovant
Arie Kovant

Arie Kovant has worked as a Director at Let There Be Hemp, Inc. since 2019 and is currently the President of AKA Advertising LLC.




















Picture Arie Sujito
Arie Sujito

Arie Sujito has a current job as an Independent Commissioner at PT Rajawali Nusantara Indonesia Persero since 2020.

No results for this search